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Implementation of a siRNA Screen for Prostate 
Tumour Cell Lines Using Living Cell Arrays
Peggy Reich, Marcus Frohme, Juha Rantala, Matthias Nees 
Zusammenfassung 
Prostatakrebs ist neben Lungenkrebs eine der häufi gsten 
Todesursachen bei Männern. In dieser Arbeit wurden 
1500 potenziell tumorrelevante Gene in drei Zelllinien 
(VCaP, LAPC-4, RWPE-1) gescreent. Dafür wurde eine neue 
Technik, die Lebendzellarrays, genutzt, um Informationen 
über die Biologie Androgen-unabhängiger Prostatazel-
len zu gewinnen. Die Lebendzellarrays basieren auf dem 
Prinzip der reversen Transfektion [1], und in Folge werden 
die mRNAs der gewünschten Gene durch spezifi sche »si-
lencer RNAs« (siRNAs) ausgeschaltet. Die Zellen wurden 
parallel sowohl in normalem Medium untersucht als auch 
mit androgen-reduziertem Medium unter Stress gesetzt. 
Das Wachstum der Prostatazellen wurde mittels Markern 
für Proliferation und Apoptose beobachtet. Die Daten der 
Screens wurden mit Hilfe statistischer Verfahren evaluiert. 
Die Lebendzellarrays konnten erfolgreich für einen um-
fangreichen SiRNA-screen angewendet werden. 
Abstract 
Prostate cancer is one of the most common causes of 
death in men. In this work a siRNA screen of around 
1500 cancer-relevant genes was performed using 3 
different cell lines (VCaP, LAPC-4, RWPE-1). A novel 
technique, the living cell array, was initiated in order 
to obtain information about the biology of Androgen-
induced growth in prostate tumour cell lines. This 
technique is based on the principal of reverse trans-
fection [1] and genes are knocked down by siRNAs. 
The cells on the living cell array were set under stress 
by reduction of the androgens in the media while the 
proliferation and apoptosis were quantifi ed. The sta-
tistical analysis of the data implicates the success of 
the screen and shows that this method is suitable for 
large-scale experiments.  
1  Introduction 
Prostate cancer (PCa) is one of most common causes 
of death for men (fi gure 1). In many cases, this malig-
nancy develops without apparent symptoms and is not 
discovered until metastases arise. In recent years, clini-
cal tests measuring the release of PSA (prostate-specifi c 
antigen) into blood serum have signifi cantly increased 
the number of cases detected at an early stage, resulting 
in much improved survival rates for these patients. Early 
diagnosis enables clinicians to successfully treat PCa us-
ing androgen ablation therapy [2]. However,  particu-
larly in advanced cases, the tumour recurs and develops 
androgen independent cells that are not responding to 
the ablation therapy, although almost invariably the an-
drogen receptor (AR) continues to be expressed. This is il-
lustrated by the fact that AR is very frequently amplifi ed 
and overexpressed in hormone-refractory cancers (HR-
PCa), or acquires mutations that cause hyper-activation 
of its functions by very low amounts of ligands. Last not 
least, other mutations allow AR to bind unrelated, even 
non-steroidal ligands. It is this development of HR-PCa 
that poses a clinical problem for which, in fact, currently 
no therapy exists. It is important to understand this de-
velopment of androgen independency to develop new 
therapeutic concepts and novel pharmaceuticals. Thus 
it is helpful to evaluate the network of relevant genes re-
lated to androgen-receptor signalling in order to model 
metabolic pathways and create hypotheses, which are 
then tested with specifi c experiments. 
Fig. 1: Cancer cases (rated per 100 000 persons) for males in the United 
States in the year 2004 [3] – data covers 98 % of the population of the 
United States 
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One of the key players in the male metabolism, Testo-
sterone, is produced by the testes and the adrenal gland 
and converted in the prostate gland by 5α-reductase to 
Dihydrotestosterone (DHT). The androgen receptor is 
located in the nucleus membrane and has a high affi n-
ity for this specifi c ligand DHT. The activated receptor 
dissociates from so called heat-shock proteins (HSP) 
and after dimerization and phosphorylation the andro-
gen receptor (AR) binds specifi cally DNA sequences, i.e. 
the androgen responsive elements (ARE). With other 
co-activators the AR stimulates – as a transcription fac-
tor – proliferation and survival as well as it inhibits ap-
optosis of the prostate cells by regulating the transcrip-
tion of androgen-responsive genes (fi g. 2) [4]. Therefore 
prostate cells are strictly dependent on androgens to 
proliferate and survive. The reduction or removal of an-
drogens in the cell culture is called androgen ablation. 
A prostate tumour may develop cells that are androgen-
independent (hormone-refractory), meaning the cells 
found a way to proliferate by bypassing the normal sig-
nalling pathway. An androgen-independent prostate 
tumour will not respond to androgen ablation therapy 
and is the most common reason for cancer recurrence. 
The investigation of how these cells manage to stimu-
late proliferation without androgens is of outstanding 
importance. 
Fig. 2: The signalling pathway of the androgen receptor (AR). Testoster-
one is transported in the blood and taken up by the androgen respon-
sive prostate cell. After transformation of testosterone to Dihydrotes-
tosterone (DHT) by 5α-reductase in the prostate cell, the DHT binds to 
the AR, which releases from the heat-shock-proteins (HSP). Then the AR 
is phosphorylated and dimerizes before it binds to androgen-response 
elements (ARA) on the DNA. With other coactivators like ARA70 and the 
general transcription apparatus (GTA) the AR regulates the transcription 
of genes to increase proliferation and survival of the prostate cells – 
modifi ed from [4]. 
This work is aimed to provide experimental data 
with information about the functions of genes in the 
prostate cell and the prostate tumour cell, with a spe-
cial focus on genes in the context of AR functions and 
HR-PCa. Living cell arrays were used to screen a library 
of siRNAs. Additionally 2 cell lines (LAPC-4, RWPE-1) 
were established on living cell arrays, to enable com-
parison and validation of the data. The establishment 
includes investigation of the attachment behaviour of 
the prostate tumour cell lines. The cell arrays were kept 
under two different conditions: In media supplied with 
suffi cient androgens and androgen ablated media. 
2  Materials and Methods 
For this study different cell lines were used: VCaP, 
LAPC-4 and RWPE-1, which were established from 
metastases of a human prostate carcinoma. The cell 
line VCaP was derived from a spinal cord metastasis of 
a PCa patient, and was initially maintained as mouse 
xenografts. The LAPC-4 cell line was established from a 
lymph node metastasis of another PCa patient, which 
was also transplanted in xenografts. VCaP and LAPC-4 
cells contain wild type AR and are androgen dependent 
(AD). Furthermore, VCaP contains a classical amplifi ca-
tion of the AR locus on the X chromosome, causing AR 
to be highly expressed in this cell line. VCaP cells are 
strongly stimulated by very low amounts of androgens. 
In contrast, LAPC-4 does not contain an AR amplifi ca-
tion and requires considerably higher concentrations 
of androgens to maintain growth and proliferation. By 
androgen ablation (= reducing/removing of androgens 
by the use of anti-androgens or charcoal-stripped se-
rum) the cells die or exist without proliferation. RWPE-
1 is a normal prostate epithelial cell line which was im-
mortalized using the oncogenes E6 and E7 of human 
papillomavirus type 18 (HPV18). In this study, RWPE-1 
cells served as the normal control. 
The living cell array (fi g. 3) was developed in the re-
search group »Medical Biotechnology« at VTT Turku 
(Technical Research Centre of Finland) [Rantala, manu-
script in preparation]. Cell arrays are essentially based 
on the concept of reverse transfection, i. e. the trans-
fection reagent is printed on a glass or plastic slide be-
fore the cells are added and left to attach. Recently, this 
experimental procedure has been described for small 
interfering (siRNA) arrays [1]. 
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Fig. 3: The principle of a living cell array. First print transfection solution, 
including siRNA and attachment factors, on a plate. Next, cells are added 
and left to attach to the printed spots. The transfection of the cells on 
the spots is performed for 2 – 3 days. After transfection, certain proteins 
of interest can be labelled by antibodies and assayed.
In vivo, these small RNAs interfere with the expres-
sion of a specifi c gene (this is also called RNAi = RNA 
interference). In vitro applied synthetic siRNAs for hu-
man cells are 19 to 25 nucleotides long, double stranded 
and have a small nucleotide overhang on both sides. It 
is mandatory for siRNAs to oblige to these size restric-
tions because long double stranded RNAs (> 30 nt) will 
effectively activate the interferon pathway which may 
lead to apoptosis and infl ammation-like artifacts. To 
introduce siRNA into human cells, an effective trans-
fection method is necessary, normally performed with 
polar lipids (e. g. lipofectamine [1]). Once introduced in 
the cell, in particular into the cytoplasm, siRNA knocks 
down specifi c genes of interest by silencing target mR-
NAs through degradation. The siRNAs bind to a complex 
named RISC, containing a number of cellular proteins 
that essentially accomplish binding of the siRNA to it’s 
mRNA target molecule, causing a cleavage of the mes-
sage followed by rapid degradation by other nucleases. 
This refers to one limitation of RNAi screens in hu-
man cells: A gene may create many different mRNAs 
through splicing – thus many independent siRNAs per 
gene are required to effi ciently knock down the gene 
[1]. Compared to the typically used liquid phase trans-
fections in 96- or 384-well plates using robotics, the »re-
verse transfection« is an extremely powerful method for 
high-throughput screening of many genes in parallel to 
gain knowledge about their function. The high density 
of the spots allows an accelerated data acquisition and 
reduces the cost and resources for each experiment. In 
particular, the volume of siRNA required is decreased 
from several microlitres per well to only a few nanoli-
tres per spot [1].
The layout of living cell arrays is variable and can be 
chosen individually.
The living cell array is printed in three steps (fi g. 4). 
Every fi eld is printed with a 16 pin print head. Three 
fi elds were printed in parallel on one slide. All three fi elds 
together are called array. One fi eld contains 16 grids (= 
784 spots). One grid contains 49 spots, 7 rows and 7 col-
umns. One spot per grid is empty (no solution printed) 
as control and orientation support. The array includes 
2352 spots. The spots have a diameter of 200 to 300 μm. 
Fig. 4: Layout of a typical living cell array with VCaP cells. A cell array is 
divided in fi elds (in green), grids (in blue) and spots (in pink). In this ap-
proach, an array contains 3 fi elds each with 16 grids each with 49 spots. 
However, this is variable and depends on the printing strategy and the 
number of siRNAs printed. 
The experimental design includes the selection of the 
siRNAs, controls, cell lines and conditions. The most 
time consuming part is to grow suffi cient numbers of 
cells for seeding the arrays and to test their attachment 
capability. After the arrays were printed, the cells were 
attached, incubated, fi xed and stained with antibodies. 
The staining was performed with an indirect immu-
noassay, using antibodies for ki67 and cParp. Ki67 is a 
protein present in the active cell cycle and widely used 
as a very reliable marker for cell proliferation. Cleaved 
Parp (cParp) is a proteolytically processed fragment 
of the poly-ADP-ribose-polymerase (PARP), which is 
cleaved during apoptosis. As fl uorescent dyes, primarily 
the very stable fl uorophores Alexa Fluor 488 and Alexa 
555 were used. The cell »cores« were stained with SYTO, 
a red fl uorescent dye that binds to DNA, thus highlight-
ing the nuclei. The performed and stained arrays were 
subsequently scanned with a fl uorescent laser scanner, 
and the intensities of the spots were measured with the 
Array-ProTM Analyzer from Inc. Media Cybernetics. The 
spot intensities were automatically normalized using a 
program written in R [Kohonen P, unpublished]. This 
algorithm fi rst normalizes the variation per grid by di-
viding every intensity value of one channel by the me-
dian of the intensities in this channel per grid (fi g. 5):
ykim = xkim/median(xim)
Here yki is the corrected intensity value and xkim is the 
uncorrected raw value of the kth spot in the ith grid in 
the mth channel, median is the median of the values in 
the ith grid in the mth channel. 
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Fig. 5: Box chart of raw and median corrected intensities. The SYTO 
(= DNA dye) intensities for the fi rst 10 grids of the VCaP cell array are 
displayed – left: raw intensity values; right: median corrected intensity 
values. The median of the grids form a line after correction. The box re- 
presents the median (horizontal black line) and the data values between 
the fi rst quartile (25 %, bottom line of box) and third quartile (75 %, top 
line of box); the whisker (vertical lines from the box) are set from 5 % 
to 95 %, the blue cross represents the mean of the data, the blue lines 
represents the maximal and minimal intensity values of the grid and the 
red dots represents the 10 % outliers. 
The intensities of the dyes vary over the array surface 
(fi g. 6). In order to smoothen these variations in the dye 
intensities, the data are normalized using the loess ap-
proach (locally weighted polynomial regression, a.k.a. 
LOWESS) [6]. The three dye/antibody channels are or-
dered pairwise (cPARP/SYTO, Ki67/SYTO, Ki67/cPARP) 
based on their position on the plate and locally fi tted 
by the loess function (fi g. 7): 
Fit = loess(rat~int+grow+gcol), 
with rat = log2 (ChannelA/ChannelB) and int = log2 
(ChannelA*ChannelB) and grow the global row and 
gcol the global column of the array represent. 
Fig. 6: Surface plot of a living cell array with VCaPs. The intensity of the 
stained nuclei using SYTO dye are plotted dependent on their location 
on the array. The array consists of 28 rows and 84 columns of spots. 
Local areas dominated by high SYTO intensities are clearly visible. These 
are smoothened using the 3-dimensional lowess correction. 
Fig. 7: Scatterplots of data values before and after the 3D-lowess-norma-
lization. The channel pair cPARP/SYTO of the living cellarray with VCaP 
is displayed – left: Scatterplot of the median-corrected data before loess 
correction; right: Scatterplot of the with lowess corrected data – LogRat 
= log2(int_cPARP/int_SYTO), LogInt = log2(int_cPARP*int_SYTO), black 
dots = data values, grey dots = 3D-lowess fi t, grey line = linear lowess 
fi t. The black dots represent the data values of the intensity ratio cParp/
Syto before lowess correction (in the left scatterplot) and after lowess 
correction (right scatterplot). The green lines represent the linear lowess 
fi t without paying attention to the position of the intensities on the array. 
The red dots show the 3D lowess fi t with attention to the position of 
the intensities on the array. The data values are corrected using the 3D 
lowess fi t, the red dots. 
3  Results 
Several test plates with printed spots containing scram-
bled siRNA (i. e. siRNA without any information and no 
expected knock-down function) were used to defi ne the 
conditions for the two cell lines LAPC-4 and RWPE-1. 
The conditions, time of enzyme treatment to detach 
the cells, the minimal cell amount needed as well as the 
time the cells require to attach were critically optimized 
and standardized conditions used to perform the actual 
screens. 
The implementation and performance of the living 
cell arrays with the three cell lines VCaP, LAPC-4 and 
RWPE-1 was successful. Several other cell lines were 
also tested, incl. the widely used LNCaP cell line, but 
resulted in unsatisfactory data. The VCaP cells were left 
to attach for 45 minutes, while the LAPC-4 cells were 
incubated for 25 minutes and the RWPE-1 cells were 
attached for one hour. All arrays were incubated for 36 
hours in the appropriate medium, whereby the media 
was changed after 12 hours. Every array was fi xed and 
stained, which required one full day per array. Eventu-
ally, the arrays were scanned and the obtained pictures 
were measured with the software Array-ProTM Analyzer. 
This process is particularly time-consuming, since every 
spot has to be estimated individually and the automatic 
software tools are not suffi ciently precise for this pur-
pose. The normalization process itself is then automati-
cally performed by the program. 
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The spots were also observed using a fl uorescence mi-
croscope (example illustrated in fi g. 8). The detailed mi-
croscopic observation of hundreds of spots in principle 
confi rmed that the antibody intensity correlates with 
the obtained values. Also, the SYTO-stained cellular 
nuclei are clearly visible, while the green fl uorescence is 
situated surrounding the nucleus, which is expected for 
the Ki67 protein that is located in the cytoplasm. 
Fig. 8: Microscopic pictures of the VCaP array spot in full RPMI and 
stripped RPMI (without androgens) – white bar = 50μm, red = nuclear  
staining (SYTO), green = cell proliferation (ki67), blue = apoptosis 
(cPARP). The apoptosis is more readily visibly in stripped, androgen-
depleted RPMI compared to full RPMI. In contrast, the proliferation/cell 
number ratio is roughly identical in both media 
For every array one technical replicate was performed 
with the same cells, at the same time to estimate the 
random error of the arrays. The random error for VCaPs 
based on the normalized ki67/cParp intensity ratios 
(logarithmic) was calculated to be around 0 ± 0.1. Two 
thirds of the values per array lie inside this range. Only 
the values that are signifi cantly higher or lower are tru-
ly interesting. The random error of the procedure is in 
a reasonable range. The reproducibility is good enough. 
To allow further evaluation of the data, some control 
siRNAs were used. Scrambled siRNAs contain no infor-
mation and no gene-specifi c knock-down should oc-
cur. The calculated mean intensities are, as expected, 
within the normal range of variation (± 0.1),  indicat-
ing that transfection alone causes serious artifi cial ef-
fects. The performance of the antibodies was evaluated 
by a gene-specifi c knock-down of the mRNAs coding 
for the proteins those antibodies are expected to detect. 
The knock-down of the protein PARP (Poly-ADP-Ri-
bose-Polymerase) decreased the intensity of the cParp 
(cleaved Parp) channel by more than 80 %. However, 
the knock-down of Ki67 decreased the intensity of the 
ki67 channel only by 5 %. This may be due to very high 
expression levels of Ki67 that are ineffi ciently targeted 
by the siRNAs, or, alternatively, indicating that the siR-
NAs against Ki67 are not working.  For this reason, fur-
ther controls such as MYC and KIF, whose knock-down 
was expected to cause cell death, were also used to con-
trol for transfection effi ciency. Their knock-down de-
creased the intensity of the ki67/cParp ratio by around 
50 %. This indicates that both the transfection of the 
cells and also the specifi city of the antibodies used were 
satisfactory. 
4  Conclusion and future aspects 
The performance of the three living cell arrays with the 
cell lines VCaP, LAPC-4 and RWPE-1 was successful. The 
obtained data were also successfully evaluated and ana-
lyzed for biological relevance (data not shown here). A 
plate-to-plate normalization will allow the comparison 
of the intensities of two cell lines or two conditions by 
using statistical methods such as the student’s t-test. 
These comparisons will produce additional functional 
information about the relevance of genes under the 
two different growth conditions examined. In particu-
lar, if the knock-down of a certain gene has no apparent 
growth effects in normal androgen-containing media 
but leads to increased cell death in androgen-reduced 
media, this may indicate a functional role of a gene in 
the androgen pathway. Most of the normalized data 
tend towards a somewhat higher variation, in particu-
lar at high intensities in both channels. Therefore an 
additional correction of the variance using loess will 
certainly improve the results. 
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